Skip to main content

Therapeutics Startups

Updated August 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,699 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,699
Total Funding
$1.4B
Avg Funding
$54.1M
Global Reach
5
countries

Top Cities for Therapeutics

Providence
Newyork
Chapel Hill
Marietta
Basel
Paris

Recently Funded Companies

Export
Providence, United States

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.

Jan 2024

Founder Contacts

41,000+ verified contacts

Newyork, United Kingdom

Mesenbio is a preclinical biopharmaceutical business based at the University of York.

$1.8M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

Chapel Hill, United States

IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.

$2.0M raised
Jan 2023

Founder Contacts

41,000+ verified contacts

Marietta, United States

BRIJ Medical, a medical device maker introduces a new age of post-surgical and trauma incision care with proven technologies.

Jan 2026

Founder Contacts

41,000+ verified contacts

Basel, Switzerland

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

$300.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.

$24.2M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

San Mateo, United States

EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.

$107.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Alachua, United States

Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.

$75.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Watertown, United States

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

$125.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Ukko is a biotechnology company focused on developing immunotherapies for the treatment of allergies and other immune-mediated diseases.

$45.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Neumirna Therapeutics is a pharmaceutical company that develops therapeutics for the treatment of neurological diseases.

$20.6M raised
Jan 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Aerwave Medical develops an alternative to traditional medications used to treat COPD and asthma.

$12.0M raised
Jan 2025

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Genomics plc aiming to lead the genomic transformation of healthcare.

$44.6M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.

$50.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.

Jan 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Soley Therapeutics combines AI with molecular and cellular response detection for developing new efficacious drugs.

$200.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

$207.5M raised
Jan 2025

Founder Contacts

41,000+ verified contacts

Carver, United States

Barologics develops disruptive technology to treat hypertension through closed-loop stimulation.

$11.5M raised
Jan 2022

Founder Contacts

41,000+ verified contacts

New York, United States

76Bio is a biotechnology company that develops therapies for patients with life-threatening diseases.

$10.0M raised
Jan 2022

Founder Contacts

41,000+ verified contacts

San Diego, United States

Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.

$2.5M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Rila Therapeutics helps with anti-fibrotic treatments, focusing on a groundbreaking HIPK2 inhibitor for kidney fibrosis.

$7.0M raised
Jan 2025

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

$100.0M raised
Jan 2023

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Solving disease-related malnutrition with a mobile clinical assistant for healthcare professionals.

$1.1M raised
Jan 2022

Founder Contacts

41,000+ verified contacts

Miami, United States

Building the infrastructure layer powering the next generation of compliant therapeutics.

$5.0M raised
Jan 2024

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

sona is a digital therapeutics company, using science-backed music to improve mental health.

$75K raised
Jan 2023

Founder Contacts

41,000+ verified contacts

Showing 1226 to 1250 of 1,699 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,699 therapeutics companies tracked in the VCBacked database.

Average Funding
$54.1M
Total Funding Tracked
$1.4B
Countries Represented
5

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.San Francisco
3 companies$208.1M
2.New York
2 companies$22.0M
3.Cambridge
2 companies$257.5M
4.Providence
1 companiesUndisclosed
5.Newyork
1 companies$1.8M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

1,699 Therapeutics Startups (2026) — Recently Funded — Page 50 | VCBacked